Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 13 matching records.
13 results — page 1 of 1
- Level DNarrative ReviewEurope PMC
Mesenchymal Stem Cell-Derived Exosomes Hold Promise in the Treatment of Diabetic Foot Ulcers
Narrative Review on Diabetic Foot, Chronic Wound, Immune Modulation, published in Int J Nanomedicine (2025) — summary generated from the PubMed abstract.
- 2025
Int J Nanomedicine7 citations - Level BClinical TrialPubMed
The promise of cell-based therapies in diabetes: A review of mesenchymal stem cell applications and trials.
Clinical Trial on Type 2 Diabetes, Immune Modulation, Autoimmune Research, published in Biochimie (2025) — summary generated from the PubMed abstract.
- 2025
Biochimie - Level BClinical TrialPubMed
Mesenchymal stem cell therapies for ARDS: translational promise and challenges.
Clinical Trial on Chronic Inflammation, Immune Modulation, published in Stem Cell Res Ther (2025) — summary generated from the PubMed abstract.
- 2025
Stem Cell Res Ther - Level BClinical TrialEurope PMC
Beyond preclinical promise: can mesenchymal stromal cell-derived extracellular vesicles reliably target tubular epithelial cells?
Clinical Trial on Chronic Kidney Disease, Acute Kidney Injury, published in Extracell Vesicles Circ Nucl Acids (2025) — summary generated from the PubMed abstract.
- 2025
Extracell Vesicles Circ Nucl Acids - Level DAnimal StudyEurope PMC
Wound Restorative Power of Halimeda macroloba / Mesenchymal Stem Cells in Immunocompromised Rats via Downregulating Inflammatory/Immune Cross Talk
Animal Study on Chronic Wound, Chronic Inflammation, published in Mar Drugs (2023) — summary generated from the PubMed abstract.
- 2023
Mar Drugs7 citations - Level DLaboratory StudyEurope PMC
Human placental mesenchymal stromal cells are ciliated and their ciliation is compromised in preeclampsia
Laboratory Study on Systemic / IV, published in BMC Med (2022) — summary generated from the PubMed abstract.
- 2022
BMC Med20 citations - Level DNarrative ReviewEurope PMC
Mesenchymal Stem Cells as a Gene Delivery Tool: Promise, Problems, and Prospects
Narrative Review, published in Pharmaceutics (2021) — summary generated from the PubMed abstract.
- 2021
Pharmaceutics27 citations - Level DAnimal StudyPubMed
The promise(s) of mesenchymal stem cell therapy in averting preclinical diabetes: lessons from in vivo and in vitro model systems.
Animal Study on Type 2 Diabetes, published in Sci Rep (2021) — summary generated from the PubMed abstract.
- 2021
Sci Rep5 citations - Level DNarrative ReviewPubMed
Synovium-Derived Mesenchymal Stem/Stromal Cells and their Promise for Cartilage Regeneration.
Narrative Review on Osteoarthritis, Cartilage Damage, published in Adv Exp Med Biol (2020) — summary generated from the PubMed abstract.
- 2020
Adv Exp Med Biol - Level CProspective StudyPubMed
Heterozygous retinoblastoma gene mutation compromises in vitro osteogenesis of adipose mesenchymal stem cells - a temporal gene expression study.
Prospective Study, published in Exp Cell Res (2020) — summary generated from the PubMed abstract.
- 2020
Exp Cell Res - Level BClinical TrialEurope PMC
Mesenchymal stem cells for inflammatory airway disorders: promises and challenges
Clinical Trial on Immune Modulation, published in Biosci Rep (2019) — summary generated from the PubMed abstract.
- 2019
Biosci Rep28 citations - Level DAnimal StudyEurope PMC
In serum veritas-in serum sanitas? Cell non-autonomous aging compromises differentiation and survival of mesenchymal stromal cells via the oxidative stress pathway
Animal Study on Systemic / IV, published in Cell Death Dis (2013) — summary generated from the PubMed abstract.
- 2013
Cell Death Dis38 citations - Level DAnimal StudyPubMed
Promise(s) of mesenchymal stem cells as an in vitro model system to depict pre-diabetic/diabetic milieu in WNIN/GR-Ob mutant rats.
Animal Study on Type 2 Diabetes, Chronic Kidney Disease, published in PLoS One (2012) — summary generated from the PubMed abstract.
- 2012
PLoS One
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406